Literature DB >> 15471875

Cyr61 suppresses growth of human endometrial cancer cells.

Wenwen Chien1, Takashi Kumagai, Carl W Miller, Julian C Desmond, Jonathan M Frank, Jonathan W Said, H Phillip Koeffler.   

Abstract

Cyr61 (CCN1) is a member of the CCN protein family; these secreted proteins are involved in diverse biological processes such as cell adhesion, angiogenesis, apoptosis, and either growth arrest or growth stimulation depending on the cellular context. We studied the role of Cyr61 in endometrial tumorigenesis. Levels of Cyr61 were decreased in endometrial tumors compared with normal endometrium. Knockdown of Cyr61 expression by RNA interference in a well differentiated endometrial adenocarcinoma cell line (Ishikawa) stimulated its cellular growth. Conversely, overexpression of the protein in the undifferentiated AN3CA endometrial cancer cell line decreased their growth concurrently with increased apoptosis in liquid culture. These same cells had decreased clonogenic capacity and a nearly complete loss of tumorigenicity in vivo. Furthermore, partially purified Cyr61 suppressed growth of endometrial cancer cells. The increased apoptosis in these endometrial cancer cells with forced overexpression of Cyr61 was associated with elevated expression of the pro-apoptotic proteins Bax, Bad, and TRAIL (tumor necrosis factor receptor-associated ligand). Cyr61-induced caspase-3 activation and depolarization of mitochondrial membrane. In summary, endometrial cancer cells have decreased expression of Cyr61 compared with normal endometrium, and this lowered expression may provide the transformed cells a growth advantage over their normal counterpart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471875     DOI: 10.1074/jbc.M410254200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.

Authors:  Amy Haseley; Sean Boone; Jeffrey Wojton; Lianbo Yu; Ji Young Yoo; Jianhua Yu; Kazuhiko Kurozumi; Joseph C Glorioso; Michael A Caligiuri; Balveen Kaur
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

3.  Dichotomous metabolism of Enterococcus faecalis induced by haematin starvation modulates colonic gene expression.

Authors:  Toby D Allen; Danny R Moore; Xingmin Wang; Viviana Casu; Randal May; Megan R Lerner; Courtney Houchen; Daniel J Brackett; Mark M Huycke
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

Review 4.  CCN1/CYR61: the very model of a modern matricellular protein.

Authors:  Lester F Lau
Journal:  Cell Mol Life Sci       Date:  2011-07-31       Impact factor: 9.261

5.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

Review 6.  Cyr61 is a potential prognostic marker for prostate cancer.

Authors:  Naoki Terada; Prakash Kulkarni; Robert H Getzenberg
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

Review 7.  G protein-coupled receptors go extracellular: RhoA integrates the integrins.

Authors:  Colin T Walsh; Dwayne Stupack; Joan Heller Brown
Journal:  Mol Interv       Date:  2008-08

8.  The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Cell Biol       Date:  2010-06-06       Impact factor: 28.824

9.  Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma pathway activation in swine aortic valve endothelium.

Authors:  Marie A Guerraty; Gregory R Grant; John W Karanian; Oscar A Chiesa; William F Pritchard; Peter F Davies
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-19       Impact factor: 8.311

10.  Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.

Authors:  Andrey S Dobroff; Hua Wang; Vladislava O Melnikova; Gabriel J Villares; Maya Zigler; Li Huang; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.